Massachusetts Eye and Ear, Mass General advancing novel gene-based COVID-19 vaccine, AAVCOVID

A unique COVID-19 genetic vaccine program is underway with Mass. Eye and Ear and Mass General Hospital, member hospitals of Mass General Brigham. The AAVCOVID vaccine program is the only gene-based vaccine approach for COVID-19 that uses adeno-associated virus (AAV), a harmless viral vector, as a delivery vehicle for inducing an immune response.